Abstract
The inflammatory response is responsible for the promotion of pannus development over the joint, which is the primary factor in joint injury in rheumatoid arthritis (RA). More in-depth investigations have been conducted in recent years leading to a greater understanding of RA. Yet, it's difficult to gauge inflammation levels in RA patients. Some people who have RA do not exhibit normal symptoms, which makes it more challenging to make a diagnosis. Typical RA evaluations are subject to a few restrictions. Earlier research demonstrated that some patients continued to experience the progression of bone and joint degeneration even while in clinical remission. This progression was attributed to ongoing synovial inflammation. As a result, performing a precise evaluation of the level of inflammation is of the utmost importance. The neutrophil-to-lymphocyte ratio (NLR) has consistently been one of the most interesting novel non-specific inflammatory indicators. It is a reflection of the equilibrium between lymphocytes and neutrophils, which are inflammatory regulators and inflammatory activators, respectively. A higher NLR is linked to more severe levels of imbalance and inflammation. The aim of this study was to depict the role of NLR in RA progression and to show if NLR could predict the response to disease-modifying antirheumatic drugs (DMARDs) therapy in RA.
Similar content being viewed by others
Data availability
It is not applicable.
References
Aarvak T, Natvig JB (2000) Cell-cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis. Arthritis Res Ther 3:1–5
Abd-Elazeem MI, Mohamed RA (2018) Neutrophil-lymphocyte and platelet-lymphocyte ratios in rheumatoid arthritis patients: Relation to disease activity. Egypt Rheumatol. https://doi.org/10.1016/j.ejr.2017.11.004
Akbarian A, Shahhosseiny MH, Vafaei S, Moslemi E, Ghahri M (2015) Designing novel and simple competitive internal amplification control for reliable PCR diagnosis of herpes simplex virus. Jundishapur J Microbiol 8:2
Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360–1372
Al-Saadany HM, Hussein MS, Gaber RA, Zaytoun HA (2016) Th-17 cells and serum IL-17 in rheumatoid arthritis patients: correlation with disease activity and severity. Egypt Rheumatol 38(1):1–7
Alunno A, Manetti M, Caterbi S, Ibba-Manneschi L, Bistoni O, Bartoloni E, Valentini V, Terenzi R, Gerli R (2015). Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications. Mediat Inflammat 2015:751793
Ashjari D, Karamali N, Rajabinejad M, Hassani SS, Hezarkhani LA, Afshari D, Karaji AG, Salari F, Rezaiemanesh A (2022) The axis of long non-coding RNA MALAT1/miR-1-3p/CXCR4 is dysregulated in patients with diabetic neuropathy. Heliyon 8(3):e09178
Biyik M, Ucar R, Solak Y, Gungor G, Polat I, Gaipov A, Cakir OO, Ataseven H, Demir A, Turk S (2013) Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 25(4):435–441
Boulos D, Proudman SM, Metcalf RG, McWilliams L, Hall C, and Wicks IP (2019) The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapy. Seminars in arthritis and rheumatism
Bugatti S, Vitolo B, Caporali R, Montecucco C, and Manzo A (2014) B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers. BioMed Res Internat
Chandrashekara S, Rajendran A, Jaganath AB, Krishnamurthy R (2015) Neutrophil-lymphocyte ratio, pain perception, and disease activity score may serve as important predictive markers for sustained remission in rheumatoid arthritis. Reumatismo 67(3):109–115
Chandrashekara S, Lingaraju DC, Renuka P, Anupama KR (2020) Potential of neutrophil to lymphocyte ratio in predicting sustained remission in rheumatoid arthritis compared to other immune activation markers. Indian J Med Res 152(3):234–243. https://doi.org/10.4103/ijmr.IJMR_1676_18
Cooles FA, Isaacs JD, Anderson AE (2013) Treg cells in rheumatoid arthritis: an update. Curr Rheumatol Rep 15:1–9
Cope AP, Schulze-Koops H, Aringer M (2007) The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol 25(5):S4
Erre GL, Paliogiannis P, Castagna F, Mangoni AA, Carru C, Passiu G, Zinellu A (2019) Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis. Eur J Clin Invest. https://doi.org/10.1111/eci.13037
Farutin V, Prodhomme T, McConnell K, Washburn N, Halvey P, Etzel CJ, Guess J, Duffner J, Getchell K, Meccariello R, Gutierrez B, Honan C, Zhao G, Cilfone NA, Gunay NS, Hillson JL, DeLuca DS, Saunders KC, Pappas DA, Capila I (2019) Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor. Arthr Res Therapy 21(1):216. https://doi.org/10.1186/s13075-019-1999-3
Fattahi A, Lotfali E, Masoumi-Asl H, Sayyahfar S, Kalani M, Khourgami MR, Yassin Z (2020) Candidemia and its risk factors in neonates and children. Arch Pediatr Infect Dis 8(4):1–5
Fresneda Alarcon M, McLaren Z, Wright HL (2021) Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: same foe different M.O. Front Immunol. https://doi.org/10.3389/fimmu.2021.649693
Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25(12):1822–1832
Ghang B, Kwon O, Hong S, Lee C-K, Yoo B, Kim Y-G (2017) Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy. Mod Rheumatol 27(3):405–410
Gökmen F, Akbal A, Reşorlu H, Binnetoğlu E, Cevizci S, Gökmen E, Köse MM, Türkyılmaz A, Akbal E (2016) Mean platelet volume and neutrophil lymphocyte ratio as related to inflammation markers and anti-CCP in rheumatoid arthritis. Aktuelle Rheumatologie 41(06):488–491
Haghighi RD (2015) Effect of ECAP and extrusion on particle distribution in Al-nano–Al 2 O 3 composite. Bull Mater Sci 38:1205–1212
Jin Z, Cai G, Zhang P, Li X, Yao S, Zhuang L, Ren M, Wang Q, Yu X (2021) The value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as complementary diagnostic tools in the diagnosis of rheumatoid arthritis: a multicenter retrospective study. J Clin Lab Anal. https://doi.org/10.1002/jcla.23569
KaramiFath M, Azargoonjahromi A, Soofi A, Almasi F, Hosseinzadeh S, Khalili S, Sheikhi K, Ferdousmakan S, Owrangi S, Fahimi M (2022) Current understanding of epigenetics role in melanoma treatment and resistance. Cancer Cell Int 22(1):1–23
Koiwa M, Goto S, Takahashi K, Kamada T, Takai S, Nakamura H (2016) Neutrophil/lymphocyte ratio in patients with rheumatoid arthritis treated with biological agents. J Nippon Med Sch 83(3):118–124
Lee YH (2018) Association between the neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and rheumatoid arthritis and their correlations with the disease activity: a meta-analysis. Journal of Rheumatic Diseases 25(3):169–178
Lee HN, Kim YK, Kim GT, Ahn E, So MW, Sohn DH, Lee SG (2019) Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-α agents in patients with rheumatoid arthritis: a retrospective chart review analysis. Rheumatol Int 39(5):859–868. https://doi.org/10.1007/s00296-019-04276-x
Li M, Xie L (2021) Correlation between NLR, PLR, and LMR and Disease Activity, Efficacy Assessment in Rheumatoid Arthritis. Evid Based Complement Alternat Med 2021:4433141. https://doi.org/10.1155/2021/4433141
Li Y, Wang W, Yang F, Xu Y, Feng C, Zhao Y (2019) The regulatory roles of neutrophils in adaptive immunity. Cell Communication and Signaling 17(1):1–11
Li C, Lin L, Zhang L, Xu R, Chen X, Ji J, Li Y (2021) Long noncoding RNA p21 enhances autophagy to alleviate endothelial progenitor cells damage and promote endothelial repair in hypertension through SESN2/AMPK/TSC2 pathway. Pharmacol Res 173:105920
Lijuan W, Yuting Z, Chaoyang L, Ju Y (2021) Neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios may not be useful markers to assess disease activity in rheumatoid arthritis: A STROBE-compliant article. Medicine 100:45
Lu L, Dong J, Liu Y, Qian Y, Zhang G, Zhou W, Zhao A, Ji G, and Xu H (2022). New insights into natural products that target the gut microbiota: effects on the prevention and treatment of colorectal cancer. Front Pharmacol 13
Makay B, Gücenmez ÖA, Duman M, Ünsal E (2014) The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch-Schonlein purpura. Rheumatol Int 34:1323–1327
Malemud CJ (2018) Defective T-Cell Apoptosis and T-Regulatory Cell Dysfunction in Rheumatoid Arthritis. Cells. https://doi.org/10.3390/cells7120223
Mandaliya H, Jones M, Oldmeadow C, Nordman II (2019) Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). Translat Lung Cancer Res 8(6):886
Meednu N, Zhang H, Owen T, Sun W, Wang V, Cistrone C, Rangel-Moreno J, Xing L, Anolik JH (2016) Production of RANKL by memory B cells: a link between B cells and bone erosion in rheumatoid arthritis. Arthr & Rheumatol 68(4):805–816
Mercan R, Bitik B, Tufan A, Bozbulut UB, Atas N, Ozturk MA, Haznedaroglu S, Goker B (2016) The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal 30(5):597–601
Mikhael EM, Ibrahim T (2013) Neutrophil/lymphocyte ratio is not correlated with disease activity in rheumatoid arthritis patients. Iraqi J Pharm Sci 22(2):9–14
Mortaz E, Alipoor SD, Adcock IM, Mumby S, Koenderman L (2018) Update on neutrophil function in severe inflammation. Front Immunol 9:2171
Orr CK, Najm A, Young F, McGarry T, Biniecka M, Fearon U, Veale DJ (2018) The utility and limitations of CRP, ESR and DAS28-CRP in appraising disease activity in rheumatoid arthritis. Front Med 5:185
Özler GS, Günak G (2014) Neutrophil-lymphocyte ratio: a new predictive and prognostic factor in patients with Bell palsy. J Cran Surg 25(3):944–945
Öztürk Z, Kuyumcu M, Yesil Y, Savas E, Yildiz H, Kepekçi Y, Arioğul S (2013) Is there a link between neutrophil-lymphocyte ratio and microvascular complications in geriatric diabetic patients? J Endocrinol Invest 36:593–599
Rapetti L, Chavele K-M, Evans CM, Ehrenstein MR (2015) B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis. Ann Rheum Dis 74(1):294–302
Rollet-Labelle E, Vaillancourt M, Marois L, Newkirk MM, Poubelle PE, Naccache PH (2013) Cross-linking of IgGs bound on circulating neutrophils leads to an activation of endothelial cells: possible role of rheumatoid factors in rheumatoid arthritis-associated vascular dysfunction. J Inflamm 10(1):1–11
Rosas C, Correa LB, and Henriques MDG (2017) Neutrophils in rheumatoid arthritis: a target for discovering new therapies based on natural products. Role Neutroph Dis Pathogen 89–118
Rossaint J, Margraf A, Zarbock A (2018) Role of platelets in leukocyte recruitment and resolution of inflammation. Front Immunol 9:2712
Samimi Z, Kardideh B, Zafari P, Bahrehmand F, Roghani SA, Taghadosi M (2019) The impaired gene expression of adenosine monophosphate-activated kinase (AMPK), a key metabolic enzyme in leukocytes of newly diagnosed rheumatoid arthritis patients. Mol Biol Rep 46:6353–6360
Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E (2005) Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 201(10):1659–1667. https://doi.org/10.1084/jem.20042321
Schulze-Koops H, Kalden JR (2001) The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 15(5):677–691
Song M, Graubard BI, Rabkin CS, Engels EA (2021) Neutrophil-to-lymphocyte ratio and mortality in the United States general population. Sci Rep 11(1):464
Sparks JA (2019) Rheumatoid Arthritis. Ann Intern Med. https://doi.org/10.7326/aitc201901010
Taylor PC, Downie B, Kim S, Hawtin R, Moots R, Takeuchi T (2021) POS0446 FILGOTINIB-treated rheumatoid arthritis patients with high baseline neutrophil-to-lymphocyte ratio show better clinical response rates and patient-reported outcomes. Ann Rheum Dis 80(Suppl 1):452–453. https://doi.org/10.1136/annrheumdis-2021-eular.850
Tian Z, Zhang Y, Zheng Z, Zhang M, Zhang T, Jin J, Zhang X, Yao G, Kong D, Zhang C (2022) Gut microbiome dysbiosis contributes to abdominal aortic aneurysm by promoting neutrophil extracellular trap formation. Cell Host Microbe 30(10):1450–1463
Uslu AU, Küçük A, Şahin A, Ugan Y, Yılmaz R, Güngör T, Bağcacı S, Küçükşen S (2015) Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Int J Rheum Dis 18(7):731–735
Vafaei S, Taheri H, Hajimomeni Y, FakhreYaseri A, Abolhasani Zadeh F (2022) The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target. Clin Transl Oncol 24(10):1881–1889
Wang L, Yu Y, Ni S, Li D, Liu J, Xie D, Chu HY, Ren Q, Zhong C, Zhang N (2022a) Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice. Theranostics 12(13):5645
Wang Z, Kong L, Zhang H, Sun F, Guo Z, Zhang R, Dou Y (2022b) Tumor Necrosis Factor Alpha -308G/A Gene Polymorphisms Combined with Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio Predicts the Efficacy and Safety of Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis Arthritis [Original Research]. Front Pharmacol. https://doi.org/10.3389/fphar.2021.811719
Wright HL, Moots RJ, Edwards SW (2014) The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol 10(10):593–601
Xue F, Cheng J, Liu Y, Cheng C, Zhang M, Sui W, Chen W, Hao P, Zhang Y, Zhang C (2022) Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice. Signal Transduct Target Ther 7(1):259
Yu Y, Wang L, Ni S, Li D, Liu J, Chu HY, Zhang N, Sun M, Li N, Ren Q (2022) Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation. Nat Commun 13(1):4241
Zafari P, Yari K, Mostafaei S, Iranshahi N, Assar S, Fekri A, Taghadosi M (2018) Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed Rheumatoid Arthritis patients. Immunol Invest 47(6):632–642
Zafari P, Taghadosi M, Faramarzi F, Rajabinejad M, Rafiei A (2023) Dimethyl fumarate inhibits fibroblast like synoviocytes-mediated inflammation and joint destruction in rheumatoid arthritis. Inflammation 46(2):612–622
Zengin O, Onder M, Kalem A, Bilici M, Türkbeyler I, Ozturk Z, Kisacik B, Onat A (2018) New inflammatory markers in early rheumatoid arthritis. Zeitschrift Rheumatol 77:2
Zhang J, Shen Q, Ma Y, Liu L, Jia W, Chen L, Xie J (2022) Calcium Homeostasis in Parkinson’s Disease: From Pathology to Treatment. Neurosci Bull 38(10):1267–1270
Zhou L, Liu Y, Sun H, Li H, Zhang Z, Hao P (2022a) Usefulness of enzyme-free and enzyme-resistant detection of complement component 5 to evaluate acute myocardial infarction. Sens Actuators, B Chem 369:132315
Zhou X, Peng W, Pan S, Lin Z, Pan R, Wang Q (2022b) High Glucose Suppresses Osteogenic Differentiation and Induces Mitochondrial Dysfunction in Osteoblasts via SIRT1/RECQL4 Axis; A Laboratory Study Using Mouse Cells. J Biol Regulat Homeost Agents 36(4):889–899
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Contributions
W.L and X.L contributed to the idea design and literature search. J.L., and L.S, wrote parts of the manuscript. T.W. contributed to designing the figure.
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
It is not applicable.
Informed consent
It is not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, X., Li, J., Sun, L. et al. The association between neutrophil-to-lymphocyte ratio and disease activity in rheumatoid arthritis. Inflammopharmacol 31, 2237–2244 (2023). https://doi.org/10.1007/s10787-023-01273-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-023-01273-2